# Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer

> **NCT01826877** · PHASE1 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- Clear Cell Renal Cell Carcinoma
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer

## Interventions

- **BIOLOGICAL:** AdGMCAIX-transduced autologous dendritic cells
- **BIOLOGICAL:** therapeutic autologous dendritic cells
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01826877
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-14
- **Primary completion:** 2018-07-03
- **Final completion:** 2021-05-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01826877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01826877, "Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01826877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*